Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF/HIF-1α/ICAM-1 signaling pathway.

about

Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF/HIF-1α/ICAM-1 signaling pathway.

Item

http://www.wikidata.org/entity/Q54940276

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Tetrandrine suppresses lung ca ...... F-1α/ICAM-1 signaling pathway.

@en

Tetrandrine suppresses lung ca ...... F-1α/ICAM-1 signaling pathway.

@nl

type

Item

label

Tetrandrine suppresses lung ca ...... F-1α/ICAM-1 signaling pathway.

@en

Tetrandrine suppresses lung ca ...... F-1α/ICAM-1 signaling pathway.

@nl

prefLabel

Tetrandrine suppresses lung ca ...... F-1α/ICAM-1 signaling pathway.

@en

Tetrandrine suppresses lung ca ...... F-1α/ICAM-1 signaling pathway.

@nl

P1476

Tetrandrine suppresses lung ca ...... F-1α/ICAM-1 signaling pathway.

@en

P2093

Feng Zhao

http://www.w3.org/2001/XMLSchema#string

Guanghai Yang

http://www.w3.org/2001/XMLSchema#string

Jian Jun Wang

http://www.w3.org/2001/XMLSchema#string

Liang Zhao

http://www.w3.org/2001/XMLSchema#string

Zhuo Chen

http://www.w3.org/2001/XMLSchema#string

P2860

The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.

Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer.

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.

Challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience

Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth.

Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo.

A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer

microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus.

A modified Phase I trial of radiation dose escalation in 3D conformal radiation therapy with concurrent vinorelbine and carboplatin chemotherapy for non-small-cell lung cancer.

P304

7433-7437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8190

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29849794

http://www.w3.org/2001/XMLSchema#string

P932

5962877

http://www.w3.org/2001/XMLSchema#string